Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Vadim V, Kozlov"'
Autor:
Igor V. Samoylenko, Lev V. Demidov, Fedor V. Moiseenko, Mikhail V. Dvorkin, Svetlana A. Demidova, Svetlana A. Protsenko, Daniil L. Stroyakovskiy, Vadim V. Kozlov, Svetlana V. Odintsova, Dmitry V. Kirtbaya, Denis A. Tantsyrev, Anastasia S. Mochalova, Rashida V. Orlova, Guzel Z. Mukhametshina, Natalia V. Fadeeva, Evgeny A. Fomin, Yana S. Chapko, Anna V. Tarasova, Nikolay B. Ermakov, Alexander K. Shemerovskiy, Vera A. Vaschenko, Valery M. Chistyakov, Arina V. Zinkina-Orikhan, Yulia N. Lin'kova, Fedor B. Kryukov, Irina V. Sorokina, Anna A. Siliutina
Publikováno v:
Современная онкология, Vol 25, Iss 3, Pp 313-324 (2023)
Background. In an era of breakthroughs in cancer immunotherapy, CheckMate 067 studies declared the combination of PD-1 and CTLA-4 inhibitors a new standard of care for patients with metastatic melanoma (MM). A significant limitation of the widespread
Externí odkaz:
https://doaj.org/article/8e208259878448f396ff73ddc1f745f9
Autor:
Elena G. Ufimtseva, Margarita S. Gileva, Ruslan V. Kostenko, Vadim V. Kozlov, Lyudmila F. Gulyaeva
Publikováno v:
Cancers, Vol 16, Iss 16, p 2886 (2024)
NSCLC is a very aggressive solid tumor, with a poor prognosis due to post-surgical recurrence. Analysis of the specific tumor and immune signatures of NSCLC samples is a critical step in prognostic evaluation and management decisions for patients aft
Externí odkaz:
https://doaj.org/article/ba22f860566440bd93745c69803ab5d9
Autor:
Alina M. Perevalova, Vladislav V. Kononchuk, Tatiana S. Kalinina, Vadim V. Kozlov, Lyudmila F. Gulyaeva, Vladimir O. Pustylnyak
Publikováno v:
Cancers, Vol 16, Iss 12, p 2208 (2024)
Smoking is an established risk factor for a variety of malignant tumors, the most well-known of which is lung cancer. Various molecular interactions are known to link tobacco smoke exposure to lung cancer, but new data are still emerging on the effec
Externí odkaz:
https://doaj.org/article/424225166f6649269f9862d0defb2549
Autor:
Vladimir O. Pustylnyak, Efim Y. Alekseenok, Alina M. Perevalova, Vadim V. Kozlov, Lyudmila F. Gulyaeva
Publikováno v:
Heliyon, Vol 9, Iss 8, Pp e19044- (2023)
Phosphatase and tensin homolog deleted on chromosome 10 (PTEN), is a tumor suppressor inactivated in a variety of human cancers. PTEN alteration correlates with lung squamous-cell carcinoma (LUSC) histology. However, it is still unclear how tobacco s
Externí odkaz:
https://doaj.org/article/0f9c6430a2884da1af1a9a3f855fd50d
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 50, Iss 1, Pp 56-64 (2022)
Rationale: Lung cancer is the leader in high mortality rates among other malignancies. This is largely due to the asymptomatic course of the disease and, as a consequence, to its late diagnosis. To optimize the oncology service of the Novosibirsk reg
Externí odkaz:
https://doaj.org/article/b4c9fb92172b4eaaa65262b5d30b4d93
Publikováno v:
Biochemistry (Moscow). 87:1219-1225
Abstract Lung cancer (LC), one of the most common malignant neoplasms, is the leading cause of high cancer mortality worldwide. Smoking is a risk factor for almost all histological types of LC. Benzo[a]pyrene (BaP), one of the main constituents of to
Autor:
Elena V. Kuligina, Vladimir A. Richter, Dmitry V. Semenov, Vadim V. Kozlov, Dmitry N. Bariakin, Anna V. Savelyeva, Elena I. Ryabchikova
Publikováno v:
BioMed Research International
BioMed Research International, Vol 2017 (2017)
BioMed Research International, Vol 2017 (2017)
Human peripheral blood contains RNA in cells and in extracellular membrane vesicles, microvesicles and exosomes, as well as in cell-free ribonucleoproteins. Circulating mRNAs and noncoding RNAs, being internalized, possess the ability to modulate vit
Autor:
Motzer RJ; Memorial Sloan Kettering Cancer Center, New York, NY., Porta C; University of Bari 'A. Moro,' Bari, Italy.; University of Pavia, Pavia, Italy., Eto M; Kyushu University, Fukuoka, Japan., Powles T; The Royal Free NHS Trust, London, United Kingdom., Grünwald V; University Hospital Essen, Essen, Germany., Hutson TE; Texas Oncology, Dallas, TX., Alekseev B; P.A. Herzen Moscow Oncological Research Institute, Moscow, Russia., Rha SY; Yonsei Cancer Center, Yonsei University Health System, Seoul, South Korea., Merchan J; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL., Goh JC; ICON Research, South Brisbane & Queensland University of Technology, Brisbane, Queensland, Australia., Lalani AA; Juravinski Cancer Centre, McMaster University, Hamilton, Ontario, Canada., De Giorgi U; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Italy., Melichar B; Palacky University, and University Hospital Olomouc, Olomouc, Czech Republic., Hong SH; Seoul St Mary's Hospital, The Catholic University of Korea, Seoul, South Korea., Gurney H; Macquarie University, Sydney, NSW, Australia., Méndez-Vidal MJ; Maimonides Institute for Biomedical research of Cordoba (IMIBIC) Hospital Universitario Reina Sofía, Medical Oncology Department, Córdoba, Spain., Kopyltsov E; State Institution of Healthcare 'Regional Clinical Oncology Dispensary,' Omsk, Russia., Tjulandin S; N N Blokhin National Medical Research Center for Oncology, Ministry of Health of the Russian Federation, Moscow, Russia., Gordoa TA; Hospital Universitario Ramón y Cajal, Madrid, Spain., Kozlov V; State budgetary Health Care Institution 'Novosibirsk Regional Clinical Oncology Dispensary,' Novosibirsk, Russia., Alyasova A; Prevoljskiy Region Medical Centre, Novgorod, Russia., Winquist E; Western University, London, Ontario, Canada., Maroto P; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Kim M; Seoul National University Hospital, Seoul, South Korea., Peer A; Rambam Health Care Campus, Haifa, Israel., Procopio G; Fondazione IRCCS Istituto Nazionale Tumori Milano, Milan, Italy., Takagi T; Tokyo Women's Medical University, Tokyo, Japan., Wong S; Western Health, Melbourne, Victoria, Australia., Bedke J; Department of Urology and Transplantation Surgery, Klinikum Stuttgart, Stuttgart, Germany., Schmidinger M; Department of Urology, Medical University of Vienna, Vienna, Austria., Rodriguez-Lopez K; Merck & Co, Inc, Rahway, NJ., Burgents J; Merck & Co, Inc, Kenilworth, NJ., He C; Eisai Inc, Nutley, NJ., Okpara CE; Eisai Ltd, Hatfield, UK., McKenzie J; Eisai Inc, Nutley, NJ., Choueiri TK; Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Apr 10; Vol. 42 (11), pp. 1222-1228. Date of Electronic Publication: 2024 Jan 16.
Autor:
Grünwald V; Interdisciplinary Genitourinary Oncology, Clinic for Urology, Clinic for Medical Oncology, University Hospital Essen, Essen, Germany. Electronic address: Viktor.Gruenwald@uk-essen.de., Powles T; The Royal Free NHS Trust, London, England, UK., Kopyltsov E; State Institution of Healthcare 'Regional Clinical Oncology Dispensary', Omsk, Russia., Kozlov V; State Budgetary Health Care Institution 'Novosibirsk Regional Clinical Oncology Dispensary', Novosibirsk, Russia., Alonso-Gordoa T; Hospital Universitario Ramón y Cajal, Madrid, Spain., Eto M; Kyushu University, Fukuoka, Japan., Hutson T; Texas Oncology, Dallas, TX, USA., Motzer R; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Winquist E; University of Western Ontario, London, Ontario, Canada., Maroto P; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Keam B; Seoul National University Hospital, Seoul, Republic of Korea., Procopio G; Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy., Wong S; Western Health, VIC, Australia., Melichar B; Palacký University Medical School and Teaching Hospital, Olomouc, Czech Republic., Rolland F; Centre René Gauducheau Centre de Lutte Contre Le Cancer Nantes, Saint-Herblain, France., Oya M; Keio University School of Medicine, Tokyo, Japan., Rodriguez-Lopez K; Merck & Co., Inc, Rahway, NJ, USA., Saito K; Eisai Inc, Nutley, NJ, USA., McKenzie J; Eisai Inc, Nutley, NJ, USA., Porta C; University of Bari 'A. Moro', Bari, Italy.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2023 Aug; Vol. 6 (4), pp. 437-446. Date of Electronic Publication: 2023 Jan 29.
Autor:
Rosenberg JE; Genitourinary Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Park SH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Kozlov V; Novosibirsk Reg Clinical Onc Dispensary, Novosibirsk, Russia., Dao TV; Vietnam National Cancer Hospital, Hanoi, Vietnam., Castellano D; Hospital Universitario 12 de Octubre, Madrid, Spain., Li JR; Taichung Veterans General Hospital, Hung Kuang University, Taichung, Taiwan., Mukherjee SD; Juravinski Cancer Centre, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada., Howells K; AstraZeneca, Cambridge, United Kingdom., Dry H; AstraZeneca, Gaithersburg, MD., Lanasa MC; AstraZeneca, Gaithersburg, MD., Stewart R; AstraZeneca, Cambridge, United Kingdom., Bajorin DF; Genitourinary Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Jan 01; Vol. 41 (1), pp. 43-53. Date of Electronic Publication: 2022 Jun 23.